首页|罗伊氏粘液乳杆菌HCS02-001缓解高尿酸血症及痛风功能的研究

罗伊氏粘液乳杆菌HCS02-001缓解高尿酸血症及痛风功能的研究

扫码查看
为探究罗伊氏粘液乳杆菌HCS02-001缓解高尿酸血症及痛风的功能,将罗伊氏粘液乳杆菌HCS02-001接种于含有肌苷、鸟苷培养液并培养一定时间后,通过测定反应液中肌苷与鸟苷含量变化来确认其体外嘌呤核苷的分解能力.将63例高尿酸血症患者随机分为对照组和干预组,2组均在基础治疗上给予碱化尿液处理,干预组额外给予罗伊氏粘液乳杆菌HCS02-001冻干粉,疗程为30 d.体外功能试验结果发现,添加罗伊氏粘液乳杆菌HCS02-001培养1 h后,肌苷与鸟苷的降解率分别为62.07%、73.53%;培养2 h后,二者的降解率分别为61.29%和67.65%.人群实验结果发现,罗伊氏粘液乳杆菌HCS02-001可显著提高患者临床总有效率,降低血清尿酸、炎症因子血清C反应蛋白(C-reactive protein,CRP)及总胆固醇(total cholesterol,TC)、甘油三酯(triglycerides,TG)和低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C)的含量,提高高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)含量,同时改善患者关节骨侵蚀现象,且具有安全性.结果表明,罗伊氏粘液乳杆菌HCS02-001可有效缓解高尿酸血症及痛风,且无不良反应.
Study on Relieving Hyperuricemia and Gout Function by Limosilactobacillus reuteri HCS02-001
To explore the function of Limosilactobacillus reuteri HCS02-001 in relieving hyperuricemia and gout,it was inoculat-ed in the culture medium containing inosine and guanosine for a certain period of time,and the content changes of inosine and guanosine in the reaction solution were determined to confirm its ability to decompose purine nucleosides in vitro.Then 63 pa-tients with hyperuricemia were randomly divided into control group and intervention group.Both groups were treated with alka-lized urine on the basis of basic treatment,and the intervention group was treated with Limosilactobacillus reuteri freeze-dried powder for 30 days.The results of functional test in vitro showed that after 1 hour of culture with Limosilactobacillus reuteri HCS02-001,the degradation rate of inosine and guanosine were 62.07%and 73.53%,respectively.After 2 hours of culture,the degradation rate of inosine and guanosine were 61.29%and 67.65%,respectively.The population experiment showed that Limosi-lactobacillus reuteri HCS02-001 could significantly increased the total clinical effective rate,reduced the content of serum uric acid,inflammatory factor serum C-reactive protein(CRP),total cholesterol(TC),triglycerides(TG),and low-density lipopro-tein cholesterol(LDL-C),increased high-density lipoprotein cholesterol(HDL-C)levels.At the same time,it is safe to improve the phenomenon of joint bone erosion in patients.In conclusion,Limosilactobacillus reuteri HCS02-001 can effectively relieve hy-peruricemia and gout without side effects.

gouthyperuricemiaLimosilactobacillus reutericlincial effectssafety

余萍、赵迪、陈雪娇、宋佳、汪海涛、闵祥博

展开 >

江西仁仁健康微生态科技有限公司,江西 樟树 331200

仁仁微生物科技研究(沈阳)有限公司,沈阳 110170

痛风 高尿酸血症 罗伊氏粘液乳杆菌 临床疗效 安全性

北京伍连德公益基金会科技创新项目

WU20220018

2024

生物技术进展
中国农业科学院茶叶研究所 中国农业科学院生物科技研究所

生物技术进展

CSTPCD
影响因子:0.554
ISSN:2095-2341
年,卷(期):2024.14(3)
  • 2